Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fusion Pharmaceuticals Inc (NQ: FUSN )

21.55 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fusion Pharmaceuticals Inc

< Previous 1 2 3 4 Next >
Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday! 
Via InvestorPlace
Fusion Pharmaceuticals's Return On Capital Employed Overview
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
Via Benzinga
Recap: Fusion Pharmaceuticals Q1 Earnings
Fusion Pharmaceuticals (NASDAQ:FUSN) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
10 Best Stocks to Buy Now According to Jeffrey Diehl’s Adams Street Partners
In this article, we will be taking a look at some of the top stocks in the portfolio of Jeffrey Diehl. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
  
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga
$1.7 Million Bet On Offerpad Solutions? Check Out These 3 Penny Stocks Insiders Are Buying
U.S. producer prices dropped 0.5% month-over-month in July, following a revised 1% increase in the previous month. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday, 52 stocks hit new 52-week lows. 
Via Benzinga
Fusion Pharmaceuticals: Q2 Earnings Insights
  Fusion Pharmaceuticals (NASDAQ:FUSN) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 15 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 73 companies hit new 52-week lows. 
Via Benzinga
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022
Upgrades 
Via Benzinga
Looking Into Fusion Pharmaceuticals's Return On Capital Employed
Fusion Pharmaceuticals (NASDAQ:FUSN) brought in sales totaling $585.00 thousand during Q1 according to data provided by Benzinga Pro. However, earnings decreased 15.51%, resulting in a loss of $19.91... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 87 companies hit new 52-week lows. 
Via Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
Photo by National Cancer Institute on Unsplash 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 77 companies made new 52-week lows. 
Via Benzinga
"Our Mission Is To Eliminate Cancer" – Here's How This Company Is Using AI In An Attempt To Save Lives
Photo by National Cancer Institute on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Baudax Bio (NASDAQ:BXRX) stock rose 32.2% to $0.26 during Thursday's pre-market session. The company's market cap stands at $21.9 million. Aptorum Group (... 
Via Benzinga
52 Biggest Movers From Yesterday
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Zogenix (NASDAQ:ZGNX) shares moved upwards by 67.2% to $26.15 during Wednesday's regular session. As of 12:30 EST, Zogenix's stock is trading at a volume... 
Via Benzinga
5 Value Stocks In The Healthcare Sector
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
Upgrades Scotiabank upgraded the previous rating for Enerplus Corp (NYSE: 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Erytech Pharma (NASDAQ:ERYP) shares moved upwards by 79.56% to $7.38 during Friday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 47.6% to $2.8198 after the company announced it received registration approval for UroShield from TGA Australia.... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.